RATIONALE: Weight gain caused by some antipsychotics is not only confined to adults but can also adversely affect both children and adolescents. Indeed, olanzapine and risperidone have been associated with extreme weight gain in adolescents even greater than that reported in adults. We have recently shown substantial weight gain in adult female rats following treatment with olanzapine and risperidone but not ziprasidone. OBJECTIVES: The aim of the present study was to compare the effects of several antipsychotics on weight gain and reproductive function in juvenile (aged 7 weeks) female hooded Lister rats. METHODS: Olanzapine (4 mg/kg), risperidone (0.5 mg/kg), ziprasidone (2.5 mg/kg), sulpiride (10 mg/kg), haloperidol (0.5 mg/kg) or vehicle was administered i.p. once per day for 21 days. Body weight, food and water intake were measured daily, in addition to the determination of stage of the oestrous cycle. RESULTS: Sub-chronic administration of olanzapine, risperidone, sulpiride and haloperidol, but not ziprasidone, significantly increased body weight compared to vehicle-treated animals during weeks 1-3. Sulpiride significantly increased food and water intake. Significantly increased percentage intra-abdominal fat weight was observed in olanzapine, risperidone, sulpiride and haloperidol, but not ziprasidone-treated animals. Marked disruption of the oestrous cycle was observed in all but the ziprasidone-treated group, which continued to have regular 4-day oestrous cycles. CONCLUSIONS: Weight gain observed in these juvenile animals was 1.5-2 times greater than that previously observed in adult rats. These findings have important implications for the use of antipsychotics in children and adolescent patients.
RATIONALE: Weight gain caused by some antipsychotics is not only confined to adults but can also adversely affect both children and adolescents. Indeed, olanzapine and risperidone have been associated with extreme weight gain in adolescents even greater than that reported in adults. We have recently shown substantial weight gain in adult female rats following treatment with olanzapine and risperidone but not ziprasidone. OBJECTIVES: The aim of the present study was to compare the effects of several antipsychotics on weight gain and reproductive function in juvenile (aged 7 weeks) female hooded Lister rats. METHODS:Olanzapine (4 mg/kg), risperidone (0.5 mg/kg), ziprasidone (2.5 mg/kg), sulpiride (10 mg/kg), haloperidol (0.5 mg/kg) or vehicle was administered i.p. once per day for 21 days. Body weight, food and water intake were measured daily, in addition to the determination of stage of the oestrous cycle. RESULTS: Sub-chronic administration of olanzapine, risperidone, sulpiride and haloperidol, but not ziprasidone, significantly increased body weight compared to vehicle-treated animals during weeks 1-3. Sulpiride significantly increased food and water intake. Significantly increased percentage intra-abdominal fat weight was observed in olanzapine, risperidone, sulpiride and haloperidol, but not ziprasidone-treated animals. Marked disruption of the oestrous cycle was observed in all but the ziprasidone-treated group, which continued to have regular 4-day oestrous cycles. CONCLUSIONS:Weight gain observed in these juvenile animals was 1.5-2 times greater than that previously observed in adult rats. These findings have important implications for the use of antipsychotics in children and adolescent patients.
Authors: Trino Baptista; A Lacruz; D De Mendoza; J M Mendoza; R Silvera; F Angeles; M T Mendoza; L Hernandez Journal: Pharmacopsychiatry Date: 2002-01 Impact factor: 5.788
Authors: U Eder; B Mangweth; C Ebenbichler; E Weiss; A Hofer; M Hummer; G Kemmler; M Lechleitner; W W Fleischhacker Journal: Am J Psychiatry Date: 2001-10 Impact factor: 18.112
Authors: Trino Baptista; Emma Araujo de Baptista; Josee Lalonde; Julie Plamondon; N M K Ng Ying Kin; Serge Beaulieu; Rhida Joober; Denis Richard Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2004-12 Impact factor: 5.067
Authors: T Baptista; Q Contreras; L Teneud; M A Albornoz; A Acosta; X Páez; M de Quijada; A LaCruz; L Hernández Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 1998-01 Impact factor: 5.067
Authors: S Kumra; J A Frazier; L K Jacobsen; K McKenna; C T Gordon; M C Lenane; S D Hamburger; A K Smith; K E Albus; J Alaghband-Rad; J L Rapoport Journal: Arch Gen Psychiatry Date: 1996-12
Authors: Emma Perez-Costas; Paolo Guidetti; Miguel Melendez-Ferro; Joyce J Kelley; Rosalinda C Roberts Journal: J Neural Transm (Vienna) Date: 2008-01-11 Impact factor: 3.575
Authors: Kieran J Davey; Siobhain M O'Mahony; Harriet Schellekens; Orla O'Sullivan; John Bienenstock; Paul D Cotter; Timothy G Dinan; John F Cryan Journal: Psychopharmacology (Berl) Date: 2012-01-11 Impact factor: 4.530
Authors: Louise Benarroch; Chantel Kowalchuk; Virginia Wilson; Celine Teo; Melanie Guenette; Araba Chintoh; Yasika Nesarajah; Valerie Taylor; Peter Selby; Paul Fletcher; Gary J Remington; Margaret K Hahn Journal: Psychopharmacology (Berl) Date: 2016-06-01 Impact factor: 4.530
Authors: M J Fell; N Anjum; K Dickinson; K M Marshall; L M Peltola; S Vickers; S Cheetham; J C Neill Journal: Psychopharmacology (Berl) Date: 2007-06-21 Impact factor: 4.415